News

Ichor Publishes Article Unraveling Evolutionary Mechanisms of Phase Separation Proteins in Extreme Microorganisms Lafayette, N.Y. – September 8, 2022 – Ichor Life

LENTO BIO RAISES $680,000 IN OVERSUBSCRIBED SEED ROUND LED BY ICHOR LIFE SCIENCES Potsdam, N.Y. – September 6, 2022 – Lento Bio,

ICHOR LIFE SCIENCES INVESTS $1.5 MILLION IN MITOCHEM THERAPEUTICS FOR OCULAR AGING DISEASE RESEARCH LaFayette, N.Y. – August 11, 2022 – Ichor

Lento Bio, Inc. Appoints Two Ichor Life Sciences Executives as a Member of the Board of Directors and Scientific Advisors Potsdam, N.Y.

ICHOR LIFE SCIENCES EXPANDS OPHTHALMOLOGY CAPABILITIES WITH CHRISTOPHER SCHILLO’S APPOINTMENT AS VIVARIUM DIRECTOR LaFayette, N.Y. – Ichor Life Sciences, a premium pre-clinical

LENTO BIO, AN ICHOR LIFE SCIENCES PORTFOLIO COMPANY, LAUNCHES WITH AIMS TO DEVELOP ANTI-GLYCATION DRUGS FOR PRESBYOPIA AND DISEASES OF AGING Potsdam,